Product Information
FENOFIBRATE 48 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0794 per EA under NDC 68180038809. Its NADAC has been published 300 times since Jan 6, 2021.
FDA first approved this application on Dec 23, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
48 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180038809
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA090856FDA Approved
12/23/2011
TE Code
AB
On Market Since
8/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 48 MG TABLET has been published 300 times since Jan 6, 2021, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0794 per EA |
|---|---|
| All-time high | $0.1464 (Jun 16, 2021) |
| All-time low | $0.0794 (Sep 23, 2026) |
| 52-week high | $0.0916 |
| 52-week low | $0.0794 |
| Median price | $0.1040 |
| Average price | $0.1051 |
| Largest weekly change | -23.1% (Apr 17, 2024) |
| Weeks tracked | 300 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fenofibrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 48 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 48 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0794 per EA (NDC 68180038809), effective Sep 30, 2026.
How has the price of FENOFIBRATE 48 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 48 MG TABLET has declined 39.7%. It has been tracked across 300 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 48 MG TABLET?
Since Jan 6, 2021, the NADAC for FENOFIBRATE 48 MG TABLET has ranged from a low of $0.0794 (Sep 23, 2026) to a high of $0.1464 (Jun 16, 2021), with a median of $0.1040 per EA.
Are there cheaper alternatives to FENOFIBRATE 48 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 48 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 48 MG TABLET?
FENOFIBRATE 48 MG TABLET (NDC 68180038809) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.